Ex-BioNTech strategy chief Ryan Richardson launches Bios Life, a $25M-backed virtual cancer surveillance startup

Ex-BioNTech strategy chief Ryan Richardson launches Bios Life, a $25M-backed virtual cancer surveillance startup

Bios Life has emerged from stealth with $25m and a Tempus data alliance to build continuous, AI-driven cancer surveillance for high-risk people and survivors.